PE
IMO APAS different niche market, huge savings to be made. BIO might have paid a penalty but I don't think they have sold any shares?
With an estimated $1.2B cost p.a for manual process, there is bound to be a return on investment for the LAB which should make it attractive.
The company is at the crossover point and with $6M in the bank no need for a capital raise either.
Our Market Cap is less than Book Value for the cost of the Tech.
The Market will price this as a divided stock, any hint of a strong uptake will see the SP multiples of where we sit today.
2C a share divided would put the SP around 30-40C IMO . We have a cash backing of 6c lol...
Cheers
- Forums
- ASX - By Stock
- LBT
- FDA Approval
FDA Approval, page-21
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.27M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.5¢ | $7.991K | 528.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 33688 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 1283725 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 33688 | 0.015 |
8 | 2702938 | 0.014 |
3 | 5487333 | 0.013 |
3 | 440000 | 0.012 |
4 | 376500 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 1283725 | 4 |
0.017 | 720000 | 3 |
0.018 | 815336 | 6 |
0.019 | 920001 | 2 |
0.020 | 2596000 | 6 |
Last trade - 15.54pm 27/08/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online